MRK Stock Analysis: Gains 0.34%, Testing Support Level
On Oktober 5, 2026: price 144.30 USD, trend sideways, RSI 46.1, support 143.79, resistance 150.91. technical analysis of mrk stock.
Merck is trying to stabilize just above recent support, but the tape still says the stock is trading in a cautious, range-bound phase rather than a clean trend. At 144.30 USD, the shares sit below the SMA20 at 146.96 but above the SMA50 at 142.29, which usually signals a market caught between short-term weakness and medium-term floor support.
Trend & Price Action
As shown in the chart, Merck’s price structure is still sideways, with the SMA20 slope down 0.63% over 5 days. That matters because a falling short-term average often reflects fading near-term momentum, even when the longer average remains intact. In practical terms, the stock is not in a decisive downtrend, but it is also not reclaiming enough ground to suggest a fresh upward leg.
The position inside the range is also telling. The stock is trading 7% of the way from support to resistance, with 20-hour support at 143.79 and 20-hour resistance at 150.91. That places MRK close to the lower end of the recent band, which can attract bargain-hunting interest, but only if buyers prove they can defend the floor. The broader 3-month range of 120.16 to 156.92 shows the current price is still well inside the year-to-date-style recovery zone, not near a breakout zone.
The key signal here is the absence of a fresh moving-average crossover. Without that shift, the chart is missing the kind of alignment that usually confirms a new directional move.
Oscillators & Momentum
The momentum picture is mixed, and that mix is the story. RSI at 46.1 is neutral, meaning the stock is neither stretched to the upside nor clearly washed out. But the Stochastic reading of 17.6 / 19.1 is in oversold territory, which often signals that short-term selling may be getting tired. The catch is that oversold does not automatically mean a rebound; it simply means the stock is closer to a point where buyers may start testing the downside.
The more important warning comes from MACD. MACD at 0.672 is still below the signal line at 1.528, and the histogram at -0.855 shows momentum remains negative. In plain language, the trend-following indicator is still leaning against the stock even while stochastic suggests pressure may be stretched. That combination often appears when a share is not yet strong enough to reverse, but may be near a short-term inflection point.
This is not a breakout setup yet.
It is a waiting setup.
Volatility & Volume
Volatility is moderate, not extreme. ATR at 3.24, or 2.2% of price, implies the stock can move enough in a session to matter, but not so violently that every move is noise. The Bollinger Bands add a useful clue: the upper band is 151.49, the middle band is 146.96, and the lower band is 142.43. With %B at 21%, price is sitting near the lower part of the band structure, which usually means the stock is trading with a downside bias inside its recent volatility envelope.
Just as important, the 6.2% Bollinger band width is narrowing, a squeeze that often precedes a stronger move. A squeeze does not tell direction, but it does tell us the market is compressing energy. When compression meets a weak MACD and oversold stochastic, the next move can be sharp — either a rebound back toward the middle band or a break below support.
Volume is not giving a strong confirmation either. 9,657,900 shares traded versus a 20-day average of 9,830,375, or about 1.0× normal. That is close enough to average to suggest the move is not being driven by a conviction surge. Meanwhile, OBV is falling, which means volume has been heavier on down days than up days. That is a subtle but important signal: even without dramatic volume spikes, the balance of participation has been leaning bearish.
Key Levels & Scenarios
The market is watching a narrow decision zone. The first line of defense is 143.79 support, reinforced by the 142.43 lower Bollinger band and the 142.29 SMA50. That cluster matters because when several indicators converge, they often create a more meaningful floor than any one level alone. On the upside, 146.96 is the first technical obstacle, followed by 150.91 resistance and the 151.49 upper Bollinger band. A move through that zone would suggest the recent weakness is fading and the stock is re-entering the upper half of its range.
If 143.79 fails, the chart opens the door to a test of the 142.43 area and potentially the 142.29 SMA50. If 146.96 is reclaimed and held, the technical picture improves, because price would be back above the short-term trend line and closer to the upper band structure.
Technical Verdict: HOLD (wait & see)
HOLD (wait & see)
- MACD remains negative, with the histogram below zero, so trend momentum has not yet turned up.
- RSI is neutral while Stochastic is oversold, a combination that hints at possible stabilization but not confirmation.
- Price is below the SMA20 and the Bollinger Bands are squeezing, which raises the odds of a move but not its direction.
Verdict invalidated if price falls below 142.29, because that would break the SMA50 support cluster and weaken the medium-term structure.
- Ideal Entry Range: 142.43 to 143.79
- Exit Target: 146.96, then 150.91
- Stop Loss Protection: below 142.29
For non-traders: Merck looks like it is pausing near support, but the chart still needs proof before the next move can be trusted.
Summary Data MRK
| Last price | 144.30 USD |
| Change 1 day / 5 days / 1 month | 0.34% / -3.01% / -5.28% |
| Trend / MA-cross | sideways / none |
| SMA20 / SMA50 | 146.96 / 142.29 |
| RSI (14) / Stochastic %K | 46.1 / 17.6 |
| Bollinger %B / ATR | 21% / 3.24 |
| Support / Resistance 20 days | 143.79 / 150.91 |
| Data as of | 2 Oktober 2026 20:30 WIB |
